Search Results

You are looking at 1 - 10 of 118 items for :

  • Biochemistry x
Clear All
Open access

Snežana Jovičić, Svetlana Ignjatović and Nada Majkić-Singh

-10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24 : 987-1003. National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). http://hin.nhlb.nih.gov/atpiii/calculator.asp?usertype=prof Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet

Open access

Iva Perović Blagojević, Svetlana Ignjatović, Djuro Macut, Jelena Kotur-Stevuljević, Ivana Božić-Antić, Jelena Vekić, Jelica Bjekić-Macut, Biljana Kastratović-Kotlica, Zoran Andrić and Dušan Ilić

, Jelić-Ivanović Z, Stefanović A, Gojković T, Joksić J et al. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients. Atherosclerosis 2015; 241: 192–8. 24. Veglia F, Cighetti G, De Franceschi M, Zingaro L, Boccotti L, Tremoli E et al. Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index. Bio-markers 2006; 11: 562–73. 25. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K et al. Adverse lipid and coronary heart disease risk profiles in young women with

Open access

Mustafa Kaplan, Ihsan Ates, Erkin Oztas, Mahmut Yuksel, Muhammed Yener Akpinar, Orhan Coskun and Ertugrul Kayacetin

pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-11. 5. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201-5. 6. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008; 57: 1698-703. 7. Aliustaoglu M, Bilici A, Ustaalioglu BB, et al. The effect of peripheral blood values on prognosis of patients

Open access

Irina Ilea, Iulia Lupan, Daniel Corneliu Leucuta, Caius Romulus Duncea and Maria Dronca

-23 6. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606. 7. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35(6): 1126-1138. 8. R Development Core Team. (2012). R (Version 2.15). Retrieved from www.r-project.org 9. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik JP, Furlong CE. Effets of 5’ regulatory region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum

Open access

Darko D. Dželajlija, Slavica S. Spasić, Jelena M. Kotur-Stevuljevic and Nataša B. Bogavac-Stanojevic

for cardiovascular health and risk reduction in children and adolescents. US De partment of Health and Human Servises, National Heath, Lung and Blood Institute. 12-7486A October 2012. 14. Morais CAS, Oliviera SHV, Lima LM. Lipid tetrad index (LTI) and lipid pentad index (LPI) in healthy subjects. Arg Bras Cardiol 2013; 100: 322-7. 15. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Mal - com GT, Tracy RE, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 2005; 165: 883-90. 16. Simeunović

Open access

Nevena Eremić and Mirjana Đerić

Cholesterol Education Program Adult Treatment Panel III Guidelines. JACC 2004; 44 (3): 720-32. National Heart Lung and Blood Institute. Framingham Heart Study. http://www.nhlbi.nih.gov/about/framingham/index.html Sarti C, Gallagher J. The metabolic syndrome. J Diabetes Complicat 2006; 20 (2): 121-32. Assman G, Cullen P, Shulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study

Open access

Irena Kafeđiska, Dejan Spasovski, Todor Gruev, Mane Grličkov, Kočo Cakalaroski, Vlado Serafimovski, Tatjana Sotirova and Petar Miloševski

References Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003; 48: 625-30. Pincus T, Amara I, Koch GG. Continuous indices of core data set measures in rheumatoid arthritis clinical

Open access

Snežana Jovičić

of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. European Society of Cardiology. HeartScore Programme the interactive tool for predicting and managing the risk of heart attack and stroke in Europe. http://www.escardio.org/knowledge/decision_tools/heartscore/ Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet 2003; 362: 1776-7. Zamaklar M. Konsenzus konferencija o promeni referentnih vrednosti

Open access

Aleksandra Klisic, Nebojsa Kavaric, Ivan Soldatovic, Bojko Bjelakovic and Jelena Kotur-Stevuljevic

References 1. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 2005; 165: 883-90. 2. Herouvi D, Karanasios E, Karayianni C, Karavanaki K. Cardiovascular disease in childhood: the role of obesity. Eur J Pediatr 2013; 172(6): 721-32. 3. Kocova M, Sukarova-Angelovska E, Tanaskoska M, Palcevska-Kocevska S, Krstevska M. Metabolic setup and risks in obese children. J Med Biochem 2015; 34: 31-7. 4

Open access

Iva Perovic Blagojevic, Tatjana Eror, Jovana Pelivanovic, Svetlana Jelic, Jelena Kotur-Stevuljevic and Svetlana Ignjatovic

adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990; 36: 15–9. 15. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 2005; 165: 883–90. 16. Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, et al. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. J Clin End Met 2016; 101: 2013–22. 17. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E